ArticleScientific reports2026
High-accuracy brain tumor detection method based on deep learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain Tumor Segmentation and Grading on MRI Using Deep Learning: A Systematic Literature Review and Benchmark-Driven Comparative Analysis.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Brain tumors remain among the most fatal diseases of the central nervous system, and early diagnosis is vital for improving patient survival outcomes. However, conventional diagnostic approaches relying on manual interpretation of MRI scans by radiologists often suffer from subjectivity, inefficiency, and a high rate of missed diagnoses. To overcome these limitations, this study introduces a systematically optimized deep learning framework designed to achieve real-time performance while preserving high detection accuracy. Specifically, we propose the A2C2f-Mona module, which enhances local and medium-range feature perception through multi-scale depthwise convolution and residual connections; design the C2PSA-DyT module, which replaces conventional normalization layers with element-wise normalization to enhance training stability and feature distribution consistency; and introduce the CGAFusion module, which integrates high- and low-level features via a channel attention mechanism, effectively improving the detection of tumors with blurred boundaries and small volumes. Experimental evaluations demonstrate that the proposed approach surpasses YOLOv12n across all performance metrics, achieving a precision of 93.8%, recall of 88.0%, and mAP@0.5 of 94.0%. Notably, the recall for pituitary tumors shows the greatest improvement, while the recognition accuracy for gliomas is also significantly enhanced. Overall, the proposed method achieves simultaneous gains in detection accuracy and stability, underscoring its substantial potential for advancing intelligent diagnosis in medical imaging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.